Market cap only $40m, $5.8m cash so no capital raising risk in the near term.
$10m+ recurring B2B revenue now. Very low revenue multiple given the growth rate when you compare against KYK or Xref.
Negative cash flow is due to expansion of B2B sales headcount. As I understand it, 12 months ago they only had 1, now it might be 4-6 people.
Ann: CV1 - Strong B2B Growth Drives Record Revenue Quarter, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add KYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.69M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 11.0¢ | $489 | 4.444K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 723809 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 25376 | 1 |
View Market Depth
| Last trade - 14.23pm 26/07/2024 (20 minute delay) ? |
| KYP (ASX) Chart |